These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6148151)

  • 21. Sertindole and impaired atrioventricular function, in the absence of Q-T prolongation: a case report.
    Rizos EN; Leftheriotis D; Douzenis A; Chatziioannou S; Siafakas N; Nika S; Kremastinos D; Lykouras L
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):442. PubMed ID: 20653911
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antipsychotic effects of caerulein on chronic schizophrenia].
    Moroharu T; Watanabe N; Ito M
    Seishin Shinkeigaku Zasshi; 1983; 85(9):611-5. PubMed ID: 6145173
    [No Abstract]   [Full Text] [Related]  

  • 23. Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis.
    Lieberman JA
    J Clin Psychiatry; 1996; 57 Suppl 11():68-71. PubMed ID: 8941173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choice of and decreasing of the dosage of risperidone in the treatment of schizophrenia. Global versus individual criteria.
    Gómez-Perretta C
    Actas Esp Psiquiatr; 2007; 35(1):77-8. PubMed ID: 17323229
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuroleptic treatment and negative symptoms in deficit and nondeficit schizophrenia.
    Bustillo JR; Kirkpatrick B; Buchanan RW
    Biol Psychiatry; 1995 Jul; 38(1):64-7. PubMed ID: 7548474
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum cholesterol and treatment-resistance in schizophrenia.
    Boston PF; Dursun SM; Zafar R; Reveley MA
    Biol Psychiatry; 1996 Sep; 40(6):542-3. PubMed ID: 8879475
    [No Abstract]   [Full Text] [Related]  

  • 27. [Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication].
    Baskak SC; Ozsan H; Baskak B; Devrimci Ozgüven H; Kinikli G
    Turk Psikiyatri Derg; 2008; 19(1):5-12. PubMed ID: 18330738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescription pattern of antipsychotic drugs for schizophrenic inpatients in Japan: research on East Asia Psychotropic Prescription Pattern-Antipsychotics study.
    Yoshimura R; Okamoto T; Nakamura J; Tateno M; Otsuka K; Takahashi H; Fujisawa D; Takamatsu T; Fujii S; Sato S; Inoue M; Sasaki H; Kuroki T; Shinfuku N
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):778-9. PubMed ID: 17109719
    [No Abstract]   [Full Text] [Related]  

  • 29. The first clinical study of BW-234U in schizophrenia.
    Davidson J; Miller R; Wingfield M; Zung W; Dren AT
    Psychopharmacol Bull; 1982 Oct; 18(4):173-6. PubMed ID: 6130560
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do we need another atypical antipsychotic?
    Kasper S
    Eur Neuropsychopharmacol; 2008 Aug; 18 Suppl 3():S146-52. PubMed ID: 18511242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychotics.
    Kilian R; Dietrich S; Toumi M; Angermeyer MC
    Acta Psychiatr Scand; 2004 Aug; 110(2):108-18. PubMed ID: 15233711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
    Marcus SC; Olfson M
    Schizophr Bull; 2008 Jan; 34(1):173-80. PubMed ID: 17578893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological treatments for first-episode schizophrenia.
    Robinson DG; Woerner MG; Delman HM; Kane JM
    Schizophr Bull; 2005 Jul; 31(3):705-22. PubMed ID: 16006592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Supportive treatment of schizophrenia--analysis of 100 cases].
    Leksowski W; Matysiakiewicz J
    Psychiatr Pol; 1984; 18(2):97-100. PubMed ID: 6151201
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clozapine for resistant schizophrenia and characteristics of those responding].
    Talmon Y; Guy N; Wittenberg N
    Harefuah; 1995 Dec; 129(11):451-4, 536. PubMed ID: 8846949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bromperidol decanoate in the residual phase of schizophrenia].
    Smeraldi E; Cocconcelli C; Canova L; Faravelli C; Marchetti FP; Mariani G; Rapisarda V
    Minerva Psichiatr; 1996 Mar; 37(1):39-44. PubMed ID: 8926856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results.
    Haro JM; Suarez D; Novick D; Brown J; Usall J; Naber D;
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):235-44. PubMed ID: 17137759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine-risperidone combination in treatment-resistant schizophrenia.
    Raju ; Kumar R; Khanna S
    Aust N Z J Psychiatry; 2001 Aug; 35(4):543. PubMed ID: 11531741
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.